Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00969319
First received: August 31, 2009
Last updated: January 16, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)